Sinus arrest during tacrolimus treatment: was the QT interval prolonged?
Calandra
S
S
D000293:Adolescent; D016026:Bone Marrow Transplantation; D004077:Digoxin / Q000009:adverse effects / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D015716:Electrocardiography, Ambulatory / Q000187:drug effects; D006323:Heart Arrest / Q000139:chemically induced*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D008133:Long QT Syndrome / Q000139:chemically induced*; D008297:Male; D013616:Tachycardia, Sinus / Q000139:chemically induced; D016559:Tacrolimus / Q000009:adverse effects* / Q000627:therapeutic use
D007166:Immunosuppressive Agents; D004077:Digoxin; D016559:Tacrolimus